Abstract
The protein therapeutics sector is a story of triumphant science, representing
both life-saving treatments for millions and a multi-billion dollar industry.
This report details both the scientific and business aspects of the protein
therapeutics marketplace, including market size and growth, competitive market
share, geographical segmentation, top products, and forecasts to 2010 for each
of the following individual product areas:
- Monoclonal Antibodies
- Erythropoietins
- Insulin
- Interferons
- Growth Factors
- Interleukins
- Blood Clotting Factors
- Tissue Plasminogen Activator
- Human Growth Hormones
- Reproductive Hormones
- Recombinant BMP-2
- Replacement Enzymes
In addition, the report discusses the major operational and strategic
challenges this market presents, including
- financing
- pricing and reimbursement,
- manufacturing
- marketing, and
- regulatory issues
Profiles of 21 key competitors-including their products, pipeline, technology
platforms, and alliances-round out the comprehensive review.
| 
View Cart
